# A Multicenter, Single Arm Study to Evaluate the Preliminary Efficacy and Safety Profile of Inavolisib in Previously Treated Pancreatic Ductal Adenocarcinoma Patients

> **NCT07694973** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Fudan University** · enrollment: 62 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma (PDAC)

## Interventions

- **DRUG:** Inavolisib

## Key facts

- **NCT ID:** NCT07694973
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-29
- **Primary completion:** 2028-06-29
- **Final completion:** 2028-07-29
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2026-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07694973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07694973, "A Multicenter, Single Arm Study to Evaluate the Preliminary Efficacy and Safety Profile of Inavolisib in Previously Treated Pancreatic Ductal Adenocarcinoma Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07694973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*